Liver transplant for hepatocellular cancer: A treatment for the select few

Clinical Transplantation

Volumn 18, Issue 2, 2004, Pages 205-210

  Wong, Linda L ^a   Tsai, Naoky ^b   Limm, Whitney ^a   Wong, Livingston ^a  

^a Hawaii Medical Center East   (United States)

^b St Francis Healthcare System of Hawaii   (United States)

Author keywords

Hepatocellular cancer; Liver transplantation; Non surgical treatments

Indexed keywords

CISPLATIN;

ADULT; AGE; AGED; CANCER CENTER; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DATA ANALYSIS; DEATH; DEMOGRAPHY; DISEASE COURSE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PATIENT REFERRAL; PATIENT SELECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME; VACCINATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 1642442633     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1399-0012.2003.00157.x     Document Type: Review

References (28)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999: 340: 745.
2. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996: 334: 693.
3. Yao FY, Ferrell L, Bass NM et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology 2001: 33: 1394.
4. El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 2000: 160: 3227.
5. El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 2002: 36: S74.
6. Seidenfeld, J, Korn A, Aronson N. Radiofrequency ablation of unresectable primary liver cancer. J Am Coll Surg 2002: 194: 813.
7. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003: 37: 429.
8. El-Serag HB, Mason AC, Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology 2001: 33: 62.
9. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients. World J Surg 1991: 15: 270.
10. Iwatsuki S, Starzl TE, Sheahan DG et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991: 214: 221.
11. Bismuth H, Chiche L, Adam R, Castaing D. Surgical treatment of hepatocellular carcinoma in cirrhosis: Liver resection or transplantation? Transplant Proc 1993:25:1066.
12. Michel J, Suc B, Fourtanier G et al. Recurrence of hepatocellular carcinoma in cirrhotic patients after liver resection or transplantation. Transplant Proc 1995: 27: 1798.
13. Vargas V, Castells L, Balsells J et al. Hepatic resection or orthotopic liver transplant in cirrhotic patients with small hepatocellular carcinoma. Transplant Proc 1995: 27: 1243.
14. Tan KC, Rela M, Ryder SD et al. Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis. Br J Surg 1995: 82: 253.
15. Otto G, Heuschen U, Hofmann WJ, Krumm G, Hinz U, Herfarth C. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: A retrospective analysis. Ann Surg 1998: 227: 424.
16. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation. Hepatology 1999: 30: 1434.
17. Weimann A, Schlitt HJ, Oldhafer KJ, Hoberg S, Tusch G, Raab R. Is liver transplantation superior to resection in early stage hepatocellular carcinoma. Transplant Proc 1999: 31: 500.
18. Figueras J, Jaurrieta E, Valls C et al. Resection of transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg 2000: 190: 580.
19. De Carlis L, Giacomoni A, Pirotta V et al. Treatment of HCC: the role of liver resection in the era of transplantation. Transplant Proc 2001: 33: 1453.
20. Okuno M, Kojima S, Hisataka M. Chemoprevention of hepatocellular carcinoma: Concept, progress and perspectives. J Gastroenterol Hepatol 2001: 16: 1329.
21. Kasahara A, Hayashi N, Mochizuki K et al. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Hepatology 1998: 27: 1394.
22. Chang MH, Chen CJ, Lai MS et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997: 336: 1855.
23. Oka H, Kurioka N, Kim K et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990: 12: 680.
24. Oka H, Tamori A, Kuroki T, Kobayshi K, Yamamoto S. Prospective study of alpha-fetoprotein I cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994: 19: 61.
25. Mima S, Sekiya C, Kanagawa H et al. Mass screening for hepatocellular carcinoma: Experience in Hokkaido, Japan. J Gastroenterol Hepatol 1994: 9: 361.
26. Curley SA, Izzo F, Gallipoli A, DeBellis M, Cremona F, Parisi V. Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular carcinoma. Ann Surg 1995: 222: 375.
27. Bolondi L, Sofia S, Siringo S et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: A cost effective analysis. Gut 2001: 48: 251.
28. Gebo KA, Chander G, Jenckes MW et al. Screening tests tor hepatocellular carcinoma in patients with chronic hepatitis C: A systematic review. Hepatology 2002: 36: S84.